Theme: The rationale of BABE studies for Pharmaceutical business and Public health BABE 2020

BABE 2020

BABE 2020

Its an enormous pleasure and feel respected to organize 11th World Congress on Bioavailability and Bioequivalence scheduled during November 26-27, 2020 at Istanbul, Turkey. The conference is mainly focussed on the theme of “The rationale of BA/BE studies for Pharmaceutical business and Public health”.

BABE 2020 is designed with the keynote sessions, session lectures, poster presentations, presentations from the young researchers, panel Discussions, and the B2B meetings with world-renowned speakers from the stream of clinical and pharmaceutical sciences. It provides the best platform for the researchers to the researchers all over globe to introduce themselves to the innovative world with their unique research. Its an open forum to discuss new researches and the challenges faced during the BA/BE studies, manufacturing the generic drugs and their effect on the public health.

Target audience:

  • CEOs, CROs, Directors, Managers and research associates
  • Academic professionals
  • Industrial Scientists
  • Regulatory and Clinical Scientists
  • Researchers, Education providers
  • Students and Postdoctoral Fellows
  • Pharmacists
  • Government Agencies
  • Medical Practitioners
  • Clinical Pharmacologists
  • Clinical Toxicologists
  • Molecular and Cellular Pharmacologist

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 26-27, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View